20
Dr Reddys Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is AMLODIPINE BESILATE USP, with a corresponding US DMF Number 16473.
Remarkably, this DMF maintains an Active status since its submission on March 19, 2003, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 21, 2013, and payment made on May 10, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II